Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Pedersen

Showing results (201-210 of 297) with videos related to

Pageof 30
Sort By:
The Journal of Physical Chemistry. B|January 16, 2024
Impact of Synergy Partner Cel7B on Cel7A Binding Rates: Insights from Single-Molecule DataAimilia Nousi, Gustavo Avelar Molina, Corinna Schiano-di-Cola, et al.
Journal of Immunological Methods|April 11, 1997
The complex between urokinase plasminogen activator and its type-1 inhibitor in breast cancer extracts quantitated by ELISAA N Pedersen, G Høyer-Hansen, N Brünner, et al.
Journal of the American Geriatrics Society|July 24, 2004
The tumor necrosis factor alpha -308G>A polymorphism is associated with dementia in the oldest oldHelle Bruunsgaard, Thomas L Benfield, Karen Andersen-Ranberg, et al.
The British Journal of Surgery|August 8, 2017
Breast cancer recurrence after reoperation for surgical bleedingR N Pedersen, K Bhaskaran, U Heide-Jørgensen, et al.
The Journal of Clinical Investigation|November 1, 1993
A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancerN Pedersen, M Schmitt, E Rønne, et al.
Physical Review Letters|May 21, 2010
Correlation-induced conductance suppression at level degeneracy in a quantum dotH A Nilsson, O Karlström, M Larsson, et al.
Biochemistry|August 25, 1992
Heparin binding to the urokinase kringle domainR W Stephens, A M Bokman, H T Myöhänen, et al.
Cell Communication and Signaling : CCS|August 25, 2020
Orchestration of signaling by structural disorder in class 1 cytokine receptorsPernille Seiffert, Katrine Bugge, Mads Nygaard, et al.
Cancer Research|May 15, 1998
The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patientsC F Sier, R Stephens, J Bizik, et al.
British Journal of Cancer|July 17, 1999
Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancerM N Holten-Andersen, G Murphy, H J Nielsen, et al.
Pageof 30

Showing results (201-210 of 297) with videos related to

Sort By:
Pageof 30
The Journal of Physical Chemistry. B|January 16, 2024
Impact of Synergy Partner Cel7B on Cel7A Binding Rates: Insights from Single-Molecule DataAimilia Nousi, Gustavo Avelar Molina, Corinna Schiano-di-Cola, et al.
Journal of Immunological Methods|April 11, 1997
The complex between urokinase plasminogen activator and its type-1 inhibitor in breast cancer extracts quantitated by ELISAA N Pedersen, G Høyer-Hansen, N Brünner, et al.
Journal of the American Geriatrics Society|July 24, 2004
The tumor necrosis factor alpha -308G>A polymorphism is associated with dementia in the oldest oldHelle Bruunsgaard, Thomas L Benfield, Karen Andersen-Ranberg, et al.
The British Journal of Surgery|August 8, 2017
Breast cancer recurrence after reoperation for surgical bleedingR N Pedersen, K Bhaskaran, U Heide-Jørgensen, et al.
The Journal of Clinical Investigation|November 1, 1993
A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancerN Pedersen, M Schmitt, E Rønne, et al.
Physical Review Letters|May 21, 2010
Correlation-induced conductance suppression at level degeneracy in a quantum dotH A Nilsson, O Karlström, M Larsson, et al.
Biochemistry|August 25, 1992
Heparin binding to the urokinase kringle domainR W Stephens, A M Bokman, H T Myöhänen, et al.
Cell Communication and Signaling : CCS|August 25, 2020
Orchestration of signaling by structural disorder in class 1 cytokine receptorsPernille Seiffert, Katrine Bugge, Mads Nygaard, et al.
Cancer Research|May 15, 1998
The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patientsC F Sier, R Stephens, J Bizik, et al.
British Journal of Cancer|July 17, 1999
Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancerM N Holten-Andersen, G Murphy, H J Nielsen, et al.
Pageof 30